NCT04689828 2026-02-20
PSMAfore
Novartis
Phase 3 Active not recruiting
Clinical Trials
3 trialsNCT03042468 2025-09-17
Phase I Dose-escalation Study of Fractionated 177Lu-PSMA-617 for Progressive Metastatic CRPC
Weill Medical College of Cornell University
Phase 1/2 Active not recruiting
NCT04716725 2024-10-16
68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer
University of California, San Francisco
Phase 2 Active not recruiting